美国Cima Labs www.cimalabs.com  www.cephalon.com
Pharmaceutical companies trust CIMA delivery technologies to commercialize new drugs and extend the product life cycle of established brands. CIMA specializes in orally disintegrating tablet (ODT), oral transmucosal (OTM) and oral powder drug delivery technologies. In addition, CIMA has expertise in taste-masking and customized release profiles.

Historical highlights:
1986 Business founded
1988 First generic product launch
1993 First ODT patent
1994 IPO
1997 First OTC ODT product launch
1999 First Rx ODT product launch
2000 Cephalon acquires Anesta company (OTS technology)
2001 Cephalon acquires Lafon company (Lyoc technology)
2004 Cephalon acquires CIMA (ODT and oral transmucosal technologies)
2004 First Rx bottled ODT U.S. product launch
2006 First OraVescent product launch
2007 All Cephalon’s drug delivery technologies are consolidated under CIMA